CLSD - Clearside Biomedical, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
4.15 -0.04 (-0.96%)	---	---	---	0.01 (0.24%)	-0.1 (-2.38%)	---	0.01 (0.24%)

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.06
Diluted EPS:: -0.06
Basic P/E:: -68.5
Diluted P/E:: -68.5
RSI(14) 1m:: 53.87
VWAP:: 4.14
RVol:: 0.2756

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	4.18 +0.05 (+1.18%)	Oct 15 15:54
1m	Price decrease 1m	4.02 -0.06 (-1.47%)	Oct 15 14:31
1m	Price increase 1m	4.15 +0.09 (+2.22%)	Oct 15 13:23
1m	Price decrease 1m	4.07 -0.06 (-1.45%)	Oct 15 11:09